| __timestamp | Amphastar Pharmaceuticals, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 10811000 |
| Thursday, January 1, 2015 | 46974000 | 33001000 |
| Friday, January 1, 2016 | 47298000 | 64936000 |
| Sunday, January 1, 2017 | 50918000 | 99909000 |
| Monday, January 1, 2018 | 58044000 | 127724000 |
| Tuesday, January 1, 2019 | 63109000 | 161524000 |
| Wednesday, January 1, 2020 | 65157000 | 182933000 |
| Friday, January 1, 2021 | 68920000 | 219982000 |
| Saturday, January 1, 2022 | 66592000 | 278139000 |
| Sunday, January 1, 2023 | 80393000 | 309799000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, from 2014 to 2023, Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses.
Ultragenyx has seen a staggering increase of over 2,700% in SG&A expenses, reflecting its aggressive growth and expansion strategies. By 2023, its expenses reached nearly three times that of Amphastar, highlighting its commitment to scaling operations and market presence.
Conversely, Amphastar's SG&A expenses grew by approximately 99%, indicating a more conservative approach. This steady growth suggests a focus on maintaining operational efficiency while gradually expanding its market footprint.
These trends underscore the differing strategic priorities of these two pharmaceutical giants, offering insights into their future market positioning.
Comparing SG&A Expenses: Zoetis Inc. vs Amphastar Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Corcept Therapeutics Incorporated vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Cytokinetics, Incorporated vs Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Rhythm Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Perrigo Company plc or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs Dynavax Technologies Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.